Enesi Pharma Limited

Silver Sponsor

Enesi Pharma is an innovative pharmaceutical company developing new products with the potential to transform performance and delivery of vaccines and make a material impact on global healthcare.


The company’s primary focus is the development of novel solid dose vaccines against a range of infectious and other select diseases, working in partnership with global companies, government agencies, leading academic institutions and non-governmental organisations.


Enesi’s ImplaVax® formulation and device technologies offer significant potential benefits for patients, care givers, healthcare professionals and payers through enhanced effectiveness, safety, ease of use, reliability and stability, and are supported by a strong patient preference over a standard needle and syringe.


The Company has established multiple collaborations to evaluate opportunities for ImplaVax®-enabled vaccines for a range of infectious diseases and allergies, including with BARDA DRIVe, Innovate UK, the University of Oxford, the Walter Reed Army Institute of Research, Public Health England, Sementis and GeoVax.


Enesi’s experienced leadership team has a proven track record in the successful development and commercialisation of innovative products delivering high value outcomes for all stakeholders.